MicroTech Medical (Hangzhou) Co., Ltd.
HKEX:2235.HK
3.69 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 71.207 | 71.207 | 55.407 | 55.407 | 50.891 | 50.891 | 35.912 | 35.912 | 45.998 | 45.998 | 29.705 | 29.705 |
| Cost of Revenue
| 38.907 | 38.907 | 26.6 | 26.6 | 26.931 | 26.931 | 20.025 | 20.025 | 26.309 | 26.309 | 13.952 | 13.952 |
| Gross Profit
| 32.3 | 32.3 | 28.807 | 28.807 | 23.96 | 23.96 | 15.887 | 15.887 | 19.689 | 19.689 | 15.753 | 15.753 |
| Gross Profit Ratio
| 0.454 | 0.454 | 0.52 | 0.52 | 0.471 | 0.471 | 0.442 | 0.442 | 0.428 | 0.428 | 0.53 | 0.53 |
| Reseach & Development Expenses
| 19.041 | 19.041 | 16.009 | 16.009 | 18.251 | 18.251 | 12.293 | 12.293 | 10.754 | 10.754 | 7.288 | 7.288 |
| General & Administrative Expenses
| 11.517 | 11.517 | 11.283 | 11.283 | 13.605 | 13.605 | 7.162 | 7.162 | 9.98 | 9.98 | 10.76 | 10.76 |
| Selling & Marketing Expenses
| 70.586 | 70.586 | 34.46 | 34.46 | 38.85 | 38.85 | 19.5 | 19.5 | 14.232 | 14.232 | 11.897 | 11.897 |
| SG&A
| 82.176 | 82.176 | 46.166 | 46.166 | 53.991 | 53.991 | 26.476 | 26.476 | 24.655 | 24.655 | 22.829 | 22.829 |
| Other Expenses
| 0 | 0 | -1.967 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 102.596 | 102.596 | 55.03 | 55.03 | 53.374 | 53.374 | 31.783 | 31.783 | 46.474 | 46.474 | 25.28 | 25.28 |
| Operating Income
| -69.473 | -69.473 | -33.221 | -33.221 | -37.777 | -37.777 | -22.394 | -22.394 | -15.72 | -15.72 | -14.363 | -14.363 |
| Operating Income Ratio
| -0.976 | -0.976 | -0.6 | -0.6 | -0.742 | -0.742 | -0.624 | -0.624 | -0.342 | -0.342 | -0.484 | -0.484 |
| Total Other Income Expenses Net
| 16.379 | 16.379 | 23.889 | 23.889 | 24.227 | 24.227 | 18.423 | 18.423 | 1.172 | 1.172 | 4.835 | 4.835 |
| Income Before Tax
| -53.095 | -53.095 | -9.332 | -9.332 | -13.55 | -13.55 | -3.971 | -3.971 | -14.549 | -14.549 | -9.528 | -9.528 |
| Income Before Tax Ratio
| -0.746 | -0.746 | -0.168 | -0.168 | -0.266 | -0.266 | -0.111 | -0.111 | -0.316 | -0.316 | -0.321 | -0.321 |
| Income Tax Expense
| 0.082 | 0.082 | -0 | 0 | 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -53.176 | -53.176 | -9.332 | -9.332 | -13.551 | -13.551 | -3.971 | -3.971 | -14.549 | -14.549 | -9.528 | -9.528 |
| Net Income Ratio
| -0.747 | -0.747 | -0.168 | -0.168 | -0.266 | -0.266 | -0.111 | -0.111 | -0.316 | -0.316 | -0.321 | -0.321 |
| EPS
| -0.13 | -0.13 | -0.022 | -0.022 | -0.03 | -0.03 | -0.01 | -0.01 | -0.038 | -0.038 | -0.027 | -0.027 |
| EPS Diluted
| -0.12 | -0.12 | -0.022 | -0.022 | -0.03 | -0.03 | -0.009 | -0.009 | -0.038 | -0.038 | -0.027 | -0.027 |
| EBITDA
| -65.118 | -65.118 | -32.391 | -32.391 | -33.513 | -33.513 | -21.584 | -21.584 | -13.669 | -13.669 | -12.473 | -12.473 |
| EBITDA Ratio
| -0.914 | -0.914 | -0.585 | -0.585 | -0.659 | -0.659 | -0.601 | -0.601 | -0.297 | -0.297 | -0.42 | -0.42 |